Is Ibogaine a Psychedelic Drug?
Yes, based on its effects. But it doesn’t work via the serotonin 5-HT2A receptor like other psychedelics.
Articles - Page 24
Scientists Synthesize and Test the Magic Mushroom Compounds Baeocystin, Norbaeocystin, Norpsilocin, and Aeruginascin
This work is a giant step forward for psychedelic research.
The Miller School of Medicine is Studying CBD + Psilocybin for Treating Traumatic Brain Injury and PTSD
The University of Miami medical school study is funded by a $1.624 million grant from Tassili Life Sciences.
Psychedelics May Aid in Deprogramming Addiction
Recent evidence suggests psychedelics may significantly improve addiction treatment outcomes.
Emotional Adjustment: The Modulatory Influence of Psilocybin on the Amygdala
Recent research suggests that psilocybin causes changes in amygdala activity opposite to those seen in conventional antidepressant treatment.
The Structure and Function of the Serotonin 5-HT1A Receptor
Activation of neuronal 5-HT1A receptors causes hyperpolarization and inhibition of cellular signaling.
Washington, DC Moves to Decriminalize Naturally Occurring Psychedelics
Decriminalize Nature DC is driving the effort to get the initiative on the November ballot.
The Structure-Activity Relationship of Two Kratom Compounds
Even slightly modifying the chemical structure of the compounds in kratom can significantly alter their effects.
UK Assessment Agency Rejects Spravato Ketamine Nasal Spray
UK Health Technology Assessment body raises questions over the clinical and cost-effectiveness of Spravato (esketamine).
Is Kratom a Psychedelic Drug?
Technically the answer is no, but subjective experiences may vary.